| pronephric nephron development | GO:0039019 | 1 | 0.980 | Zebrafish |
| renal system process | GO:0003014 | 48 | 0.841 | |
| kidney development | GO:0001822 | 213 | 0.776 | Zebrafish |
| glomerular basement membrane development | GO:0032836 | 8 | 0.743 | |
| transmembrane transport | GO:0055085 | 412 | 0.680 | Mouse |
| urogenital system development | GO:0001655 | 261 | 0.651 | Zebrafish |
| glomerulus development | GO:0032835 | 40 | 0.644 | Zebrafish |
| renal filtration cell differentiation | GO:0061318 | 10 | 0.624 | |
| renal system development | GO:0072001 | 225 | 0.581 | Zebrafish |
| regulation of peptidase activity | GO:0052547 | 96 | 0.569 | |
| glomerular epithelial cell development | GO:0072310 | 6 | 0.557 | |
| inter male aggressive behavior | GO:0002121 | 3 | 0.551 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.549 | |
| spermatogenesis | GO:0007283 | 284 | 0.512 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.484 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.483 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.481 | Mouse |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.481 | |
| myotube differentiation | GO:0014902 | 105 | 0.475 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.473 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.467 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.441 | |
| cell adhesion | GO:0007155 | 329 | 0.434 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.426 | |
| cell cell adhesion | GO:0098609 | 41 | 0.400 | |
| extracellular structure organization | GO:0043062 | 148 | 0.396 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.392 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.387 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.372 | |
| organic acid transport | GO:0015849 | 101 | 0.365 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.364 | |
| regulation of endocytic recycling | GO:2001135 | 3 | 0.364 | |
| carnitine transmembrane transport | GO:1902603 | 3 | 0.361 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.359 | |
| regulation of ion transport | GO:0043269 | 215 | 0.354 | Mouse |
| glomerular visceral epithelial cell development | GO:0072015 | 6 | 0.347 | |
| anion transport | GO:0006820 | 177 | 0.344 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.332 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.331 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.322 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.321 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.321 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.306 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.303 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.302 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.301 | |
| male gamete generation | GO:0048232 | 285 | 0.298 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.297 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.293 | |
| cation transport | GO:0006812 | 399 | 0.291 | Mouse |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.289 | |
| digestive tract development | GO:0048565 | 190 | 0.282 | |
| amine metabolic process | GO:0009308 | 45 | 0.281 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.277 | |
| carnitine transport | GO:0015879 | 3 | 0.276 | |
| response to peptide hormone | GO:0043434 | 127 | 0.276 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.273 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.271 | |
| spermatid differentiation | GO:0048515 | 115 | 0.270 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.268 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.265 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.256 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.255 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.246 | |
| glomerular epithelium development | GO:0072010 | 11 | 0.244 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.239 | |
| muscle cell development | GO:0055001 | 133 | 0.239 | |
| germ cell development | GO:0007281 | 185 | 0.235 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.234 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.232 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.231 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.231 | |
| atp metabolic process | GO:0046034 | 75 | 0.231 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.231 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.229 | |
| nephron development | GO:0072006 | 109 | 0.229 | Zebrafish |
| organic anion transport | GO:0015711 | 137 | 0.228 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.227 | |
| response to growth factor | GO:0070848 | 198 | 0.226 | |
| spermatid development | GO:0007286 | 108 | 0.222 | |
| endocytosis | GO:0006897 | 168 | 0.209 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.206 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.203 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.201 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.197 | |
| maintenance of epithelial cell apical basal polarity | GO:0045199 | 2 | 0.194 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.192 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.190 | |
| intracellular protein transport | GO:0006886 | 204 | 0.188 | |
| neuronal action potential | GO:0019228 | 54 | 0.187 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.186 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.186 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.185 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.184 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.184 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.183 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.182 | |
| positive regulation of syncytium formation by plasma membrane fusion | GO:0060143 | 17 | 0.181 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.180 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.179 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.179 | |
| cell junction organization | GO:0034330 | 77 | 0.177 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.176 | |
| defense response to other organism | GO:0098542 | 197 | 0.176 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.175 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.174 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.174 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.172 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.167 | |
| glomerular epithelial cell differentiation | GO:0072311 | 10 | 0.166 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.165 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.164 | |
| atp catabolic process | GO:0006200 | 55 | 0.161 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.159 | |
| oxidation reduction process | GO:0055114 | 342 | 0.156 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.155 | |
| response to peptide | GO:1901652 | 136 | 0.152 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.148 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 34 | 0.148 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.148 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.148 | |
| forebrain development | GO:0030900 | 302 | 0.147 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.146 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.146 | |
| locomotory behavior | GO:0007626 | 195 | 0.145 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.143 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.142 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.142 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.142 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.141 | |
| lipid homeostasis | GO:0055088 | 63 | 0.140 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.140 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.138 | |
| regulation of defense response | GO:0031347 | 233 | 0.137 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.137 | |
| action potential | GO:0001508 | 78 | 0.136 | |
| positive regulation of endocytic recycling | GO:2001137 | 2 | 0.134 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.133 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.132 | |
| positive regulation of myotube differentiation | GO:0010831 | 24 | 0.131 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.131 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.131 | |
| dna metabolic process | GO:0006259 | 303 | 0.130 | |
| urate transport | GO:0015747 | 1 | 0.129 | |
| ossification | GO:0001503 | 216 | 0.128 | |
| response to nutrient levels | GO:0031667 | 109 | 0.128 | |
| regulation of cell activation | GO:0050865 | 289 | 0.128 | |
| cell cell junction organization | GO:0045216 | 72 | 0.128 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.127 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.125 | |
| protein maturation | GO:0051604 | 176 | 0.124 | |
| epithelial cell development | GO:0002064 | 159 | 0.124 | |
| carbohydrate transport | GO:0008643 | 62 | 0.122 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.120 | |
| syncytium formation | GO:0006949 | 43 | 0.118 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.117 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.117 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.115 | |
| actin filament polymerization | GO:0030041 | 44 | 0.115 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.115 | |
| glomerulus morphogenesis | GO:0072102 | 10 | 0.114 | |
| axon ensheathment | GO:0008366 | 76 | 0.114 | |
| amino acid transport | GO:0006865 | 61 | 0.113 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.113 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.112 | |
| protein polymerization | GO:0051258 | 57 | 0.112 | |
| actin filament organization | GO:0007015 | 113 | 0.109 | |
| mesoderm development | GO:0007498 | 100 | 0.107 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.107 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.106 | |
| sterol homeostasis | GO:0055092 | 45 | 0.106 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.104 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.103 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.103 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.103 | |
| motor neuron migration | GO:0097475 | 4 | 0.103 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.102 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.102 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.102 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.102 | |
| post embryonic organ development | GO:0048569 | 17 | 0.101 | |
| defense response to virus | GO:0051607 | 68 | 0.101 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.101 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.100 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.100 | |
| digestion | GO:0007586 | 40 | 0.099 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.099 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.098 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.098 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.098 | |
| response to insulin | GO:0032868 | 100 | 0.098 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.096 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.095 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.094 | |
| immune effector process | GO:0002252 | 321 | 0.094 | |
| mitochondrion organization | GO:0007005 | 134 | 0.093 | |
| muscle tissue development | GO:0060537 | 308 | 0.093 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.092 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.091 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.090 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.090 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.089 | |
| positive regulation of actin filament polymerization | GO:0030838 | 26 | 0.088 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.088 | |
| ureteric bud development | GO:0001657 | 94 | 0.088 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.085 | |
| deoxyribonucleotide biosynthetic process | GO:0009263 | 6 | 0.085 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.085 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.084 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.084 | |
| renal filtration | GO:0097205 | 7 | 0.083 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.083 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.083 | |
| response to vitamin d | GO:0033280 | 3 | 0.083 | |
| visual perception | GO:0007601 | 52 | 0.082 | |
| nephron epithelium development | GO:0072009 | 92 | 0.082 | |
| regulation of myeloid dendritic cell activation | GO:0030885 | 5 | 0.082 | |
| monosaccharide transport | GO:0015749 | 58 | 0.082 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.082 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.081 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.081 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.079 | |
| regulation of protein localization | GO:0032880 | 231 | 0.079 | |
| blood circulation | GO:0008015 | 195 | 0.078 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.078 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.077 | |
| hair cycle | GO:0042633 | 90 | 0.077 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.077 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.077 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.077 | |
| synaptic transmission | GO:0007268 | 329 | 0.077 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.077 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.076 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.076 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.076 | |
| response to amino acid | GO:0043200 | 37 | 0.076 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.075 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.073 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.073 | |
| adherens junction organization | GO:0034332 | 28 | 0.073 | |
| tube formation | GO:0035148 | 140 | 0.072 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.070 | |
| glucose transport | GO:0015758 | 56 | 0.070 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.070 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.070 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.070 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.070 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.069 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.069 | |
| response to corticosterone | GO:0051412 | 1 | 0.069 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.069 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.068 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.068 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.068 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.068 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.067 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.067 | |
| glomerular filtration | GO:0003094 | 7 | 0.067 | |
| neuron migration | GO:0001764 | 122 | 0.067 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.067 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.067 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.066 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.066 | |
| maintenance of apical basal cell polarity | GO:0035090 | 3 | 0.066 | |
| protein targeting | GO:0006605 | 143 | 0.065 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.065 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.065 | |
| chemotaxis | GO:0006935 | 247 | 0.065 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.064 | |
| glucose metabolic process | GO:0006006 | 92 | 0.064 | |
| regulation of wound healing | GO:0061041 | 40 | 0.064 | |
| regulation of secretion | GO:0051046 | 274 | 0.064 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.063 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.062 | |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.062 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.062 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.062 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.062 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.062 | |
| embryonic placenta development | GO:0001892 | 98 | 0.062 | |
| neural tube development | GO:0021915 | 160 | 0.061 | |
| angiogenesis | GO:0001525 | 201 | 0.061 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.061 | |
| carnitine metabolic process | GO:0009437 | 7 | 0.061 | |
| regulation of neuron death | GO:1901214 | 134 | 0.061 | |
| nuclear division | GO:0000280 | 158 | 0.060 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.059 | |
| protein processing | GO:0016485 | 163 | 0.059 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.059 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.059 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.058 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.058 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.058 | |
| defense response to protozoan | GO:0042832 | 25 | 0.057 | |
| camera type eye development | GO:0043010 | 266 | 0.057 | |
| sperm individualization | GO:0007291 | 1 | 0.057 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.057 | |
| neurotransmitter uptake | GO:0001504 | 14 | 0.057 | |
| connective tissue development | GO:0061448 | 179 | 0.056 | |
| neural tube formation | GO:0001841 | 108 | 0.056 | |
| humoral immune response | GO:0006959 | 57 | 0.056 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.055 | |
| trigeminal sensory nucleus development | GO:0021730 | 2 | 0.055 | |
| odontogenesis | GO:0042476 | 78 | 0.054 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.054 | |
| protein localization to membrane | GO:0072657 | 108 | 0.054 | |
| glomerular visceral epithelial cell differentiation | GO:0072112 | 10 | 0.054 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.054 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.054 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.054 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.053 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.052 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.052 | |
| lipid localization | GO:0010876 | 126 | 0.052 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.052 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.052 | |
| heterophilic cell cell adhesion via plasma membrane cell adhesion molecules | GO:0007157 | 20 | 0.052 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.051 | |
| cation homeostasis | GO:0055080 | 212 | 0.051 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.051 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.050 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.050 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.050 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.049 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.049 | |
| regulation of protein processing | GO:0070613 | 96 | 0.049 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.049 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.049 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.049 | |
| learning or memory | GO:0007611 | 148 | 0.048 | |
| response to fructose | GO:0009750 | 2 | 0.048 | |
| adrenal cortex development | GO:0035801 | 2 | 0.047 | |
| organelle fission | GO:0048285 | 170 | 0.047 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.047 | |
| nerve development | GO:0021675 | 67 | 0.047 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.047 | |
| oviduct development | GO:0060066 | 3 | 0.046 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.046 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.046 | |
| female gamete generation | GO:0007292 | 74 | 0.045 | |
| digestive system development | GO:0055123 | 200 | 0.045 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.045 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.045 | Mouse |
| negative regulation of growth | GO:0045926 | 99 | 0.044 | |
| response to oxidative stress | GO:0006979 | 123 | 0.044 | |
| sensory perception | GO:0007600 | 245 | 0.043 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.043 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.043 | |
| cellular response to peptide | GO:1901653 | 92 | 0.043 | |
| muscle fiber development | GO:0048747 | 76 | 0.043 | |
| kidney epithelium development | GO:0072073 | 121 | 0.042 | |
| sodium ion transport | GO:0006814 | 73 | 0.042 | Mouse |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.042 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.042 | |
| positive regulation of receptor internalization | GO:0002092 | 4 | 0.042 | |
| lateral motor column neuron migration | GO:0097477 | 3 | 0.042 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.042 | Mouse |
| positive regulation of cell migration | GO:0030335 | 109 | 0.041 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.041 | |
| inorganic anion transport | GO:0015698 | 43 | 0.041 | |
| adherens junction assembly | GO:0034333 | 22 | 0.041 | |
| myelination | GO:0042552 | 74 | 0.041 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.041 | |
| homophilic cell adhesion via plasma membrane adhesion molecules | GO:0007156 | 18 | 0.040 | |
| glucose import | GO:0046323 | 32 | 0.040 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.040 | |
| modified amino acid transport | GO:0072337 | 5 | 0.040 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.040 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.039 | |
| rhombomere 3 morphogenesis | GO:0021658 | 2 | 0.039 | |
| gliogenesis | GO:0042063 | 141 | 0.039 | |
| autophagy | GO:0006914 | 45 | 0.039 | |
| skin development | GO:0043588 | 220 | 0.039 | |
| hormone metabolic process | GO:0042445 | 86 | 0.039 | |
| histamine uptake | GO:0051615 | 1 | 0.038 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.038 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.038 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.038 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.038 | |
| positive regulation of growth | GO:0045927 | 104 | 0.038 | |
| cell junction assembly | GO:0034329 | 52 | 0.038 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.037 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.037 | |
| defense response to bacterium | GO:0042742 | 119 | 0.037 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.037 | Mouse |
| innate immune response | GO:0045087 | 157 | 0.037 | |
| positive regulation of endothelial cell chemotaxis | GO:2001028 | 1 | 0.037 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.037 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.037 | |
| regulation of release of cytochrome c from mitochondria | GO:0090199 | 11 | 0.037 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.037 | |
| adrenal cortex formation | GO:0035802 | 2 | 0.037 | |
| regulation of cell migration | GO:0030334 | 219 | 0.036 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.036 | |
| regulation of cell size | GO:0008361 | 72 | 0.036 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.036 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.036 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.036 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.036 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.036 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.036 | |
| leukocyte migration | GO:0050900 | 124 | 0.036 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.036 | |
| monoamine transport | GO:0015844 | 33 | 0.035 | |
| dopamine uptake involved in synaptic transmission | GO:0051583 | 4 | 0.035 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.035 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.035 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.035 | |
| axonogenesis | GO:0007409 | 274 | 0.034 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.034 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.034 | |
| establishment of monopolar cell polarity | GO:0061162 | 8 | 0.034 | |
| mesenchyme development | GO:0060485 | 152 | 0.034 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.034 | |
| stem cell differentiation | GO:0048863 | 268 | 0.034 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.034 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.034 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.034 | |
| placenta development | GO:0001890 | 140 | 0.033 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.033 | |
| neutrophil mediated immunity | GO:0002446 | 19 | 0.033 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.033 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.033 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.033 | |
| filopodium assembly | GO:0046847 | 19 | 0.033 | |
| cellular response to oxygen levels | GO:0071453 | 20 | 0.033 | |
| nuclear transport | GO:0051169 | 139 | 0.032 | |
| somitogenesis | GO:0001756 | 69 | 0.032 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.032 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.032 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.032 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.032 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.032 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.032 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.032 | |
| glial cell differentiation | GO:0010001 | 131 | 0.032 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.032 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.032 | |
| fat cell differentiation | GO:0045444 | 160 | 0.032 | |
| regulation of cell motility | GO:2000145 | 236 | 0.032 | |
| cellular response to starvation | GO:0009267 | 57 | 0.031 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.031 | |
| tissue homeostasis | GO:0001894 | 115 | 0.031 | |
| inflammatory response | GO:0006954 | 244 | 0.031 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.031 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.031 | |
| cell growth | GO:0016049 | 130 | 0.031 | |
| hindbrain development | GO:0030902 | 128 | 0.031 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.031 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.031 | |
| regulation of system process | GO:0044057 | 200 | 0.031 | |
| somite development | GO:0061053 | 81 | 0.031 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.030 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.030 | |
| medulla oblongata development | GO:0021550 | 3 | 0.030 | |
| gamma aminobutyric acid metabolic process | GO:0009448 | 3 | 0.030 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.030 | |
| cell junction maintenance | GO:0034331 | 4 | 0.030 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.030 | |
| plasma membrane organization | GO:0007009 | 90 | 0.030 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.030 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.030 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.029 | |
| gastrulation | GO:0007369 | 116 | 0.029 | |
| response to radiation | GO:0009314 | 165 | 0.029 | |
| negative regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900212 | 4 | 0.029 | |
| t cell proliferation | GO:0042098 | 120 | 0.029 | |
| cell recognition | GO:0008037 | 83 | 0.029 | |
| multicellular organism growth | GO:0035264 | 161 | 0.029 | |
| regulation of axon extension | GO:0030516 | 43 | 0.029 | |
| response to oxygen levels | GO:0070482 | 62 | 0.029 | |
| protein targeting to plasma membrane | GO:0072661 | 7 | 0.029 | |
| diaphragm development | GO:0060539 | 5 | 0.029 | |
| norepinephrine transport | GO:0015874 | 2 | 0.029 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 22 | 0.028 | |
| l amino acid transport | GO:0015807 | 32 | 0.028 | |
